Selected research
Market Outlook & Growth Opportunities
Global EUV Pellicle Market Outlook and Growth Opportunities 2026
Market perspective
The global EUV Pellicle market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for EUV Pellicle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for EUV Pellicle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for EUV Pellicle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the EUV Pellicle market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the EUV Pellicle market include Mitsui Chemicals, S&S Tech, Canatu, TSMC and FST, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global EUV Pellicle market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of EUV Pellicle and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents EUV Pellicle sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EUV Pellicle market size, projected growth trends, production technologies, key applications, and end-use industries.
EUV Pellicle Segment by Company
Mitsui Chemicals
S&S Tech
Canatu
TSMC
FST
EUV Pellicle Segment by Type
≥90% transmittance
<90% transmittance
EUV Pellicle Segment by Application
IDM
Foundry
EUV Pellicle Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global EUV Pellicle status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions EUV Pellicle market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify EUV Pellicle significant trends, drivers, influence factors in global and regions.
6. To analyze EUV Pellicle competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EUV Pellicle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EUV Pellicle and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EUV Pellicle.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the EUV Pellicle market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EUV Pellicle industry.
Chapter 3: Detailed analysis of EUV Pellicle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of EUV Pellicle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of EUV Pellicle in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- ≥90% transmittance
- <90% transmittance
Applications
- IDM
- Foundry
Companies covered
- Mitsui Chemicals
- S&S Tech
- Canatu
- TSMC
- FST
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global EUV Pellicle Sales Value (2021-2032)
- 1.2.2 Global EUV Pellicle Sales Volume (2021-2032)
- 1.2.3 Global EUV Pellicle Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 EUV Pellicle Market Dynamics
- 2.1 EUV Pellicle Industry Trends
- 2.2 EUV Pellicle Industry Drivers
- 2.3 EUV Pellicle Industry Opportunities and Challenges
- 2.4 EUV Pellicle Industry Restraints
3 EUV Pellicle Market by Company
- 3.1 Global EUV Pellicle Company Revenue Ranking in 2025
- 3.2 Global EUV Pellicle Revenue by Company (2021-2026)
- 3.3 Global EUV Pellicle Sales Volume by Company (2021-2026)
- 3.4 Global EUV Pellicle Average Price by Company (2021-2026)
- 3.5 Global EUV Pellicle Company Ranking (2024-2026)
- 3.6 Global EUV Pellicle Company Manufacturing Base and Headquarters
- 3.7 Global EUV Pellicle Company Product Type and Application
- 3.8 Global EUV Pellicle Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global EUV Pellicle Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 EUV Pellicle Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 EUV Pellicle Market by Type
- 4.1 EUV Pellicle Type Introduction
- 4.1.1 ≥90% transmittance
- 4.1.2 <90% transmittance
- 4.2 Global EUV Pellicle Sales Volume by Type
- 4.2.1 Global EUV Pellicle Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global EUV Pellicle Sales Volume by Type (2021-2032)
- 4.2.3 Global EUV Pellicle Sales Volume Share by Type (2021-2032)
- 4.3 Global EUV Pellicle Sales Value by Type
- 4.3.1 Global EUV Pellicle Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global EUV Pellicle Sales Value by Type (2021-2032)
- 4.3.3 Global EUV Pellicle Sales Value Share by Type (2021-2032)
5 EUV Pellicle Market by Application
- 5.1 EUV Pellicle Application Introduction
- 5.1.1 IDM
- 5.1.2 Foundry
- 5.2 Global EUV Pellicle Sales Volume by Application
- 5.2.1 Global EUV Pellicle Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global EUV Pellicle Sales Volume by Application (2021-2032)
- 5.2.3 Global EUV Pellicle Sales Volume Share by Application (2021-2032)
- 5.3 Global EUV Pellicle Sales Value by Application
- 5.3.1 Global EUV Pellicle Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global EUV Pellicle Sales Value by Application (2021-2032)
- 5.3.3 Global EUV Pellicle Sales Value Share by Application (2021-2032)
6 EUV Pellicle Regional Sales and Value Analysis
- 6.1 Global EUV Pellicle Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global EUV Pellicle Sales by Region (2021-2032)
- 6.2.1 Global EUV Pellicle Sales by Region: 2021-2026
- 6.2.2 Global EUV Pellicle Sales by Region (2027-2032)
- 6.3 Global EUV Pellicle Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global EUV Pellicle Sales Value by Region (2021-2032)
- 6.4.1 Global EUV Pellicle Sales Value by Region: 2021-2026
- 6.4.2 Global EUV Pellicle Sales Value by Region (2027-2032)
- 6.5 Global EUV Pellicle Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America EUV Pellicle Sales Value (2021-2032)
- 6.6.2 North America EUV Pellicle Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe EUV Pellicle Sales Value (2021-2032)
- 6.7.2 Europe EUV Pellicle Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific EUV Pellicle Sales Value (2021-2032)
- 6.8.2 Asia-Pacific EUV Pellicle Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America EUV Pellicle Sales Value (2021-2032)
- 6.9.2 South America EUV Pellicle Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa EUV Pellicle Sales Value (2021-2032)
- 6.10.2 Middle East & Africa EUV Pellicle Sales Value Share by Country, 2025 VS 2032
7 EUV Pellicle Country-level Sales and Value Analysis
- 7.1 Global EUV Pellicle Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global EUV Pellicle Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global EUV Pellicle Sales by Country (2021-2032)
- 7.3.1 Global EUV Pellicle Sales by Country (2021-2026)
- 7.3.2 Global EUV Pellicle Sales by Country (2027-2032)
- 7.4 Global EUV Pellicle Sales Value by Country (2021-2032)
- 7.4.1 Global EUV Pellicle Sales Value by Country (2021-2026)
- 7.4.2 Global EUV Pellicle Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.5.2 USA EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.9.2 France EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.16.2 China EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.19.2 India EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran EUV Pellicle Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt EUV Pellicle Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt EUV Pellicle Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt EUV Pellicle Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Mitsui Chemicals
- 8.1.1 Mitsui Chemicals Company Information
- 8.1.2 Mitsui Chemicals Business Overview
- 8.1.3 Mitsui Chemicals EUV Pellicle Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Mitsui Chemicals EUV Pellicle Product Portfolio
- 8.1.5 Mitsui Chemicals Recent Developments
- 8.2 S&S Tech
- 8.2.1 S&S Tech Company Information
- 8.2.2 S&S Tech Business Overview
- 8.2.3 S&S Tech EUV Pellicle Sales, Value and Gross Margin (2021-2026)
- 8.2.4 S&S Tech EUV Pellicle Product Portfolio
- 8.2.5 S&S Tech Recent Developments
- 8.3 Canatu
- 8.3.1 Canatu Company Information
- 8.3.2 Canatu Business Overview
- 8.3.3 Canatu EUV Pellicle Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Canatu EUV Pellicle Product Portfolio
- 8.3.5 Canatu Recent Developments
- 8.4 TSMC
- 8.4.1 TSMC Company Information
- 8.4.2 TSMC Business Overview
- 8.4.3 TSMC EUV Pellicle Sales, Value and Gross Margin (2021-2026)
- 8.4.4 TSMC EUV Pellicle Product Portfolio
- 8.4.5 TSMC Recent Developments
- 8.5 FST
- 8.5.1 FST Company Information
- 8.5.2 FST Business Overview
- 8.5.3 FST EUV Pellicle Sales, Value and Gross Margin (2021-2026)
- 8.5.4 FST EUV Pellicle Product Portfolio
- 8.5.5 FST Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 EUV Pellicle Value Chain Analysis
- 9.1.1 EUV Pellicle Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 EUV Pellicle Sales Mode & Process
- 9.2 EUV Pellicle Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 EUV Pellicle Distributors
- 9.2.3 EUV Pellicle Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst